“…Amplifications of the MYC and MLL genes have been previously reported in acute myeloid leukemia (AML), [2][3][4] and of AML1 and MLL in ALL. 3,5 Although amplification of the BCR/ABL fusion gene has been described in cases of chronic myeloid leukemia (CML) treated with imatinib mesylate, seen both as HSRs 6 and dmins, 7 amplification of ABL alone is rare. A six-fold and a 15-fold amplification of the gene have been described in the CML-derived cell line, K562, 8 and in a patient with CML in lymphoid blast crisis, respectively.…”